Cases 1 - 10 of 10
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
as 1:2023cv00926
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
as 2:2023cv00926
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Covis Pharma GmbH et al v. Eugia Pharma Specialties Ltd. et al
as 1:2022cv00971
Plaintiff:
Covis Pharma GmbH, AMAG Pharma USA, Inc. and AMAG Pharmaceuticals, Inc.
Defendant:
Eugia Pharma Specialties Ltd., Aurobindo Pharma, Ltd., Aurobindo Pharma U.S.A., Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Aurobindo Pharma USA, Inc. et al
as 1:2022cv00295
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. and Eugia Pharma Specialties Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Ferring Pharmaceuticals Inc. et al v. Eugia Pharma Specialties Ltd. et al
as 1:2022cv00017
Plaintiff:
Ferring Pharmaceuticals Inc., Ferring International Center S.A., Ferring B.V. and others
Defendant:
Eugia Pharma Specialties Ltd., Aurobindo Pharma Ltd. and AuroMedics Pharma LLC
Cause Of Action: 35 U.S.C. § 271
BRISTOL-MYERS SQUIBB COMPANY v. EUGIA PHARMA SPECIALTIES, LTD.
as 2:2021cv20409
Plaintiff:
BRISTOL-MYERS SQUIBB COMPANY
Defendant:
EUGIA PHARMA SPECIALTIES, LTD.
Cause Of Action: 35 U.S.C. § 271
Covis Pharma GmbH et al v. Eugia Pharma Specialties Ltd. et al
as 1:2021cv00003
Plaintiff:
AMAG Pharmaceuticals, Inc., AMAG Pharma USA, Inc. and Covis Pharma GmbH
Defendant:
Aurobindo Pharma, Ltd., Aurobindo Pharma U.S.A., Inc. and Eugia Pharma Specialties Ltd.
Cause Of Action: 35 U.S.C. § 1
Pfizer Inc. et al v. Aurobindo Pharma, Ltd. et al
as 1:2020cv01528
Defendant:
Aurobindo Pharma USA, Inc., Aurobindo Pharma, Ltd. and Eugia Pharma Specialties Ltd.
Plaintiff:
Pfizer Inc., Warner-Lambert Company LLC and PF PRISM IMB B.V.
Cause Of Action: 35 U.S.C. § 271
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court:
Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re:
In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al. v. Aurobindo Pharma, Ltd. et al.
as 1:2019cv00748
Defendant:
Aurobindo Pharma USA, Inc., Aurobindo Pharma, Ltd. and Eugia Pharma Specialties Ltd.
Plaintiff:
Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
